Biotec chief executive appointed to government advisory panel




June 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, wither
The chief executive of Biotec Services International Dr Fiona Withey has been appointed to
provide guidance to the Welsh government on …
PMCPA raps Pharmaxis
June 16, 2014Manufacturing and Production, Sales and Marketing ABPI, CML, PMCPA, pharmaxis
Pharmaxis Pharmaceuticals has been given the most severe punishment that the PMCPA can hand out following a series of breaches …
NHS staff face prison
June 13, 2014Sales and Marketing Francis, Mid Staffs, NHS, berwick, prison
The government is to create a new statutory criminal offence of ill-treatment or wilful neglect of patients, which could see …
Google takes on Samsung and Apple in health
June 13, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, fit, fitness, google, health kit, sambaed, wearable
Google is to launch a health platform to rival Samsung’s SAMI offering and Apple’s HealthKit into an ever-expanding technology marketplace. …
NICE recommends Yervoy
June 13, 2014Sales and Marketing BMS, Cancer, Dillon, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has received a lift from the UK’s drugs watchdog, which has recommended its vaccine Yervoy as a first-line …
Healthcare at Home names interim chief
June 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing healthcare at home, natalie douglas
Clinical services firm Healthcare at Home has appointed Natalie Douglas as interim chief executive, as Mike Gordon becomes non-executive chairman. …
AbbVie highlights treatment adherence
June 12, 2014Sales and Marketing ALIGN, AbbVie, Abbott, Crohn’s disease, TNF, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, treatment, ulcerative colitis
Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …
AstraZeneca signs $240m asthma deal with UK biotech
June 12, 2014Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
Lonza adds executive committee member
June 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, sven Abend
Sven Abend is joining Swiss chemicals and biotech giant Lonza to serve on its executive committee. From July Abend will …
Novo Nordisk outlines hiring plans
June 12, 2014Sales and Marketing Denmark, Novo Nordisk, diabetes, haemostasis, pharma
Novo Nordisk has outlined ambitious plans for the medium-term, saying it will look to hire 6,000 staff in its native …
Bristol-Myers Squibb hires new general manager




June 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, Johanna Mercier
Johanna Mercier has been appointed as Bristol-Myers Squibb’s general manager for the UK and Ireland. The appointment of Mercier who …
Allergan rejects Valeant – again
June 11, 2014Research and Development, Sales and Marketing Allergan, Botox, Valeant, pershing, pharma
Allergan and Valeant Pharmaceuticals International are continuing their stately dance around one another – and in the latest move the …
Researchers question ‘bias’ NICE on statins
June 11, 2014Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins
Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …
Cello hires digital director from YouGov
June 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, brilot, yougov
Healthcare market research agency Cello Health Insight has appointed a new digital director in Dan Brilot. Brilot is to work …
MediCity hub moves forward
June 11, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BioCity, alderley park, johnson, medcity, medicity
Nine new businesses have signed tenancy agreements at Nottingham’s MediCity, bringing to 20 the number of companies which have been …
InterMune drops EMA lawsuit over data release
June 10, 2014Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung
InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …
Merck buys Idenix
June 10, 2014Manufacturing and Production, Sales and Marketing HCV, IDX21437, IDX21459, Merck, hep C, idenix
Merck is to improve its pipeline of hepatitis C virus (HCV) treatments by splashing out $3.85 billion on biopharma firm …
Dendreon chief resigns from struggling firm
June 10, 2014Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate
Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …
Sovaldi hurdles first drug pricing barrier
June 10, 2014Sales and Marketing Gilead, SMC, Scotland, hep C, sofosbuvir, sovaldi
Scotland’s NHS will pay for Gilead’s new hepatitis C pill Sovaldi despite rising concern over its high cost. The Scottish …
Langland hires business unit director
June 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langland, Michael Le Brocq
Healthcare advertising agency Langland has appointed Michael Le Brocq as business unit director for its Ethical division. Also joining the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
